Table 1. Baseline characteristics.
| 2-Month prednisolone (n=124) | 6-Month prednisolone (n=122) | P-value | |
|---|---|---|---|
| Male, n (%) | 89 (71.8) | 87 (71.3) | 0.94 |
| Age, mean (s.d.), years | 6.7 (4.1) | 6.3 (4.1) | 0.42 |
| Age group, years | |||
| 1–5, n (%) | 67 (54.0) | 66 (54.1) | 0.99 |
| 6–10, n (%) | 33 (26.6) | 33 (27.1) | |
| 11–15, n (%) | 24 (19.4) | 23 (18.9) | |
| Blood pressure, mean (s.d.), mm Hg | |||
| Systolic | 104.4 (10.7) | 106.4 (12.0) | 0.16 |
| Diastolic | 62.4 (10.0) | 62.5 (11.3) | 0.98 |
| Serum albumin, mean (s.d.), g/l | 1.4 (0.5) | 1.4 (0.5) | 0.90 |
| Hospital, n (%) | |||
| General | 47 (65.3) | 46 (64.8) | 1.00 |
| Children's | 7 (9.7) | 7 (9.9) | |
| University | 18 (25.0) | 18 (25.4) | |
| Quarterly distribution of disease onset, n (%) | |||
| January–March | 23 (18.7) | 24 (19.7) | 0.99 |
| April–June | 36 (29.3) | 34 (27.9) | |
| July–September | 30 (24.4) | 31 (25.4) | |
| October–December | 34 (27.6) | 33 (27.0) | |
| Duration from the first episode to remission, mean (s.d.), days | 9.7 (3.1) | 10.0 (3.1) | 0.45 |
Abbreviation: s.d., standard deviation.